Kube D - Search Results

1

Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.

Bohlen H, Hopff T, Manzke O, Engert A, Kube D, Wickramanayake PD, Diehl V, Tesch H. Bohlen H, et al. Among authors: kube d. Blood. 1993 Sep 15;82(6):1803-12. Blood. 1993. PMID: 7691238 Free article.

2

Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.

Bohlen H, Manzke O, Titzer S, Lorenzen J, Kube D, Engert A, Abken H, Wolf J, Diehl V, Tesch H. Bohlen H, et al. Among authors: kube d. Cancer Res. 1997 May 1;57(9):1704-9. Cancer Res. 1997. PMID: 9135012

3

STAT3 is constitutively activated in Hodgkin cell lines.

Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, Heinrich PC, Diehl V, Tesch H. Kube D, et al. Blood. 2001 Aug 1;98(3):762-70. doi: 10.1182/blood.v98.3.762. Blood. 2001. PMID: 11468177 Free article.

4

Interleukin 10 inhibits cytokine production of human AML cells.

Westermann F, Kube D, Haier B, Bohlen H, Engert A, Zuehlsdorf M, Diehl V, Tesch H. Westermann F, et al. Among authors: kube d. Ann Oncol. 1996 Apr;7(4):397-404. doi: 10.1093/oxfordjournals.annonc.a010607. Ann Oncol. 1996. PMID: 8805932 Free article.

5

Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease.

Vockerodt M, Soares M, Kanzler H, Küppers R, Kube D, Hansmann ML, Diehl V, Tesch H. Vockerodt M, et al. Among authors: kube d. Blood. 1998 Oct 15;92(8):2899-907. Blood. 1998. PMID: 9763576 Free article.

6

Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells.

Horn PA, Tesch H, Staib P, Kube D, Diehl V, Voliotis D. Horn PA, et al. Among authors: kube d. Blood. 1999 Feb 15;93(4):1435-7. Blood. 1999. PMID: 10075457 Free article. No abstract available.

7

Expression of p56lck in B-cell neoplasias.

Von Knethen A, Abts H, Kube D, Diehl V, Tesch H. Von Knethen A, et al. Among authors: kube d. Leuk Lymphoma. 1997 Aug;26(5-6):551-62. doi: 10.3109/10428199709050891. Leuk Lymphoma. 1997. PMID: 9389362

8

Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.

Kube D, Vockerodt M, Weber O, Hell K, Wolf J, Haier B, Grässer FA, Müller-Lantzsch N, Kieff E, Diehl V, Tesch H. Kube D, et al. J Virol. 1999 Feb;73(2):1630-6. doi: 10.1128/JVI.73.2.1630-1636.1999. J Virol. 1999. PMID: 9882370 Free PMC article.

9

Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.

Vockerodt M, Tesch H, Kube D. Vockerodt M, et al. Among authors: kube d. Genes Immun. 2001 Dec;2(8):433-41. doi: 10.1038/sj.gene.6363803. Genes Immun. 2001. PMID: 11781710

10

Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.

Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, Tesch H. Kube D, et al. Cytokine. 1995 Jan;7(1):1-7. doi: 10.1006/cyto.1995.1001. Cytokine. 1995. PMID: 7749063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page